ロード中...
Metformin treatment reduces temozolomide resistance of glioblastoma cells
It has been reported that metformin acts synergistically with temozolomide (TMZ) to inhibit proliferation of glioma cells including glioblastoma multiforme (GBM). However, the molecular mechanism underlying how metformin exerts its anti-cancer effects remains elusive. We used a combined experimental...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5346677/ https://ncbi.nlm.nih.gov/pubmed/27791206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12859 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|